Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.23.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Series A Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Series A Preferred Stock [Member]
Total
Balance, beginning of period (in shares) at Dec. 31, 2021   0            
Issuance of Series A-5 preferred stock at $1,000 per share (Note 6) (in shares) 0              
Balance, end of period (in shares) at Mar. 31, 2022   0            
Balance, beginning of period at Dec. 31, 2021   $ 0 $ 46,000   $ 215,943,000 $ (125,292,000)    
Issuance of Series A-5 preferred stock at $1,000 per share (Note 6) $ 0     $ 0        
Balance, beginning of period (in shares) at Dec. 31, 2021     36,809,187          
Stock-based compensation (in shares)     55,770          
Balance, end of period (in shares) at Mar. 31, 2022     36,864,957          
Stock-based compensation         1,099,000      
Net Loss           (7,916,000)   $ (7,916,000)
Balance, end of period at Mar. 31, 2022   $ 0 $ 46,000   217,042,000 (133,208,000)   $ 83,880,000
Balance, beginning of period (in shares) at Dec. 31, 2021   0            
Issuance of Series A-5 preferred stock at $1,000 per share (Note 6) (in shares)             5,359 10,323
Balance, end of period (in shares) at Dec. 31, 2022   10,323            
Balance, beginning of period at Dec. 31, 2021   $ 0 $ 46,000   215,943,000 (125,292,000)    
Balance, beginning of period (in shares) at Dec. 31, 2021     36,809,187          
Balance, end of period (in shares) at Dec. 31, 2022     37,605,973         37,605,973
Balance, end of period at Dec. 31, 2022   $ 0 $ 47,000   229,900,000 (210,743,000)   $ 19,204,000
Issuance of Series A-5 preferred stock at $1,000 per share (Note 6) (in shares) 2,299             12,622
Balance, end of period (in shares) at Mar. 31, 2023   12,622            
Issuance of Series A-5 preferred stock at $1,000 per share (Note 6) $ 0     $ 1,919,000        
Stock-based compensation (in shares)     189,104          
Balance, end of period (in shares) at Mar. 31, 2023     37,795,077         37,795,077
Stock-based compensation         720,000      
Net Loss           (7,236,000)   $ (7,236,000)
Balance, end of period at Mar. 31, 2023   $ 0 $ 47,000   $ 232,539,000 $ (217,979,000)   $ 14,607,000